Skip to main content
Clinical Trials/NCT06281795
NCT06281795
Recruiting
Not Applicable

Neuromodulation of the Autonomic Nervous System in Athletes (NANSA Trial)

Bakulev Scientific Center of Cardiovascular Surgery1 site in 1 country125 target enrollmentApril 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Efficacy, Self
Sponsor
Bakulev Scientific Center of Cardiovascular Surgery
Enrollment
125
Locations
1
Primary Endpoint
Dynamics of maximum oxygen consumption (VO2max).
Status
Recruiting
Last Updated
10 months ago

Overview

Brief Summary

There are few studies in the literature that have evaluated the effects of using percutaneous stimulation of the auricular branch of the vagus nerve for sports purposes (to accelerate recovery after physical exertion). It has been demonstrated that tVNS in athletes improved the rate of heart rate recovery, reduced lactic acid levels in blood plasma, reduced pain, reduced overtraining syndrome and fatigue levels.

Detailed Description

Several studies have shown that transcutaneous vagus nerve stimulation (tVNS) potentially exhibits therapeutic effects similar to its invasive counterpart. tVNS is performed using surface electrodes and low-frequency electrical currents, targeting specific locations, most commonly the auricular branch of the vagus nerve or its cervical branch. Stimulation of the auricular branch of the vagus nerve activates vagal sensory fibers, simulating sensory input to the brainstem and forming what is known as the auriculo-vagal afferent pathway. Since these fibers project directly to the nucleus of the solitary tract (also known as the solitary tract nucleus), which in turn has direct or indirect projections to nuclei that provide noradrenergic, endorphinergic, and serotonergic fibers in various parts of the brain, regulating systemic parameters of cardiovascular, respiratory, and immune functions, it can be expected that the body's response to stimulation of the auricular branch of the vagus nerve will be systemic. With the onset of physical exercise, sympathetic activity in the body increases and reaches a plateau value after a certain period of maximum activity. After the end of physical exercise, suppressed parasympathetic activity begins to intensify, and the sympathetic system gradually returns to a resting state. After training, parasympathetic system activation continues for up to 48 hours. In certain types of training, when the frequency of anaerobic respiration increases during physical exertion, a decrease in parasympathetic reactivation may be observed. In the literature, there are individual studies that have evaluated the effects of transcutaneous stimulation of the auricular branch of the vagus nerve for sports purposes (to accelerate recovery processes after physical exertion). It has been demonstrated that tVNS in athletes improves heart rate recovery, reduces lactate levels in plasma, reduces pain sensations, decreases overtraining syndrome, and reduces fatigue levels. The aim of this study is to: evaluate the influence of low-frequency electrical stimulation of the auricular branch of the vagus nerve on the functional reserve of the cardiovascular and respiratory systems in athletes during the post-training period, after high-intensity workouts.

Registry
clinicaltrials.gov
Start Date
April 1, 2024
End Date
January 31, 2026
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Bakulev Scientific Center of Cardiovascular Surgery
Responsible Party
Principal Investigator
Principal Investigator

Vladimir A Shvartz, MD

MD, DM, Professor

Bakulev Scientific Center of Cardiovascular Surgery

Eligibility Criteria

Inclusion Criteria

  • Professional athletes over the age of 15 and under the age of 35;
  • Cyclic sports (swimming, modern pentathlon, athletics, triathlon);
  • Difficult coordination sports (dance sports, rhythmic gymnastics);
  • Sports category: no lower than candidate for master of sports;
  • Voluntary informed consent.

Exclusion Criteria

  • Atypical and unrelated to physical exertion changes on the ECG (T wave inversion, st-segment depression, pathological Q waves, signs of left atrial enlargement, signs of right ventricular hypertrophy, ventricular pre-excitation, complete right or left bundle branch block, prolonged or shortened Q-T interval, Brugada-like early repolarization);
  • Heart rhythm and conduction disorders (frequent ventricular and supraventricular extrasystoles, first-degree atrioventricular block (P-Q \> 0.21 s, not shortened during hyperventilation or physical exertion), second or third degree);
  • Expressed sinus bradycardia with resting heart rate \< 40 bpm;
  • Taking glucocorticosteroids in the last 1 month;
  • Taking any antiarrhythmic drugs, including beta-blockers.

Outcomes

Primary Outcomes

Dynamics of maximum oxygen consumption (VO2max).

Time Frame: The level of VO2max is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and fictitious stimulation groups.

During a cardiorespiratory exercise test, the level of VO2max (ml/min/kg) is assessed.

The dynamics of the treadmill speed at the level of the anaerobic threshold of metabolism.

Time Frame: Treadmill speed is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and dummy stimulation groups.

During the cardiorespiratory exercise test, the treadmill speed (km/h) is estimated at the level of the anaerobic metabolic threshold.

Secondary Outcomes

  • The dynamics of the heart rate (HR) at the level of the anaerobic threshold of metabolism.(HR is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and dummy stimulation groups.)
  • The dynamics of the heart rate (HR) at the level of the aerobic threshold of metabolism.(HR is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and dummy stimulation groups.)
  • HF dynamics(This parameter is evaluated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the groups of active and fictitious stimulation.)
  • The dynamics of RMSSD.(This parameter is evaluated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the groups of active and fictitious stimulation.)
  • Dynamics of the treadmill speed at the level of the aerobic metabolism threshold of metabolism.(Treadmill speed is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and dummy stimulation groups.)
  • Dynamics of the LF/HF ratio.(This LF/HF ratio is evaluated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and fictitious stimulation groups.)

Study Sites (1)

Loading locations...

Similar Trials